Analyst Ranking
Bottom 7%
#4822 out of 5156 analysts
Average Return
-13.45%
Win Rate
16%3 out of 19
Risk vs Reward
Poor
Good

Yale Jen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+463.67%$11.81$66.57
2024-07-28 -
2025-07-28
Strong Buy
Newcelx LtdNCEL
+80.00%$240.04$432.00
2022-09-05 -
2023-09-05
Strong Buy
Evofem Biosciences IncEVFM
+38.95%$0.34$0.48
2022-06-01 -
2022-08-10
Strong Buy

Yale Jen Analyst Color

Get additional color on Yale Jen's coverage of popular stocks

Yale Jen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Palatin Technologies IncPTN
1Strong Buy$60.00+214.30%Initiates Coverage On
7 days ago
Femasys IncFEMY
1Strong Buy$6.50+715.56%Initiates Coverage On
a month ago
Nasus Pharma LtdNSRX
1Strong Buy$22.00+245.37%Initiates Coverage On
3 months ago
Senti Biosciences IncSNTI
1Strong Buy$5.00+327.35%Initiates Coverage On
6 months ago
Soleno Therapeutics IncSLNO
1Strong Buy$105.00+117.03%Maintains
9 months ago
Nuvectis Pharma IncNVCT
1Strong Buy$19.00+138.10%Initiates Coverage On
9 months ago
Lifeward LtdLFWD
1Strong Buy$10.00+1,370.59%Initiates Coverage On
10 months ago
Abivax SaABVX
1Strong Buy$48.00N/AInitiates Coverage On
a year ago
Affimed NvAFMDQ
1Strong Buy$25.00N/AMaintains
2 years ago
Biomx IncPHGE
1Strong Buy$475.00N/AInitiates Coverage On
2 years ago
In8bio IncINAB
1Strong Buy$225.00N/AInitiates Coverage On
2 years ago
Silo Pharma IncSILO
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Bellerophon Therapeutics IncBLPH
1Strong Buy$35.00N/AInitiates Coverage On
3 years ago
Newcelx LtdNCEL
1Strong Buy$240.00N/AInitiates Coverage On
3 years ago
Evofem Biosciences IncEVFM
1Strong Buy$3.50N/AInitiates Coverage On
4 years ago
Cingulate IncCING
1Strong Buy$2,040.00N/AInitiates Coverage On
4 years ago
Vincerx Pharma IncVINC
1Strong Buy$600.00N/AInitiates Coverage On
4 years ago
F Star Therapeutics IncFSTX
1Strong Buy$32.00N/AInitiates Coverage On
5 years ago
Athenex IncATNXQ
1Strong Buy$720.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.